FDA, CMS Task Force Seeks Sweet Spot For Lab Quality Oversight
This article was originally published in The Gray Sheet
Executive Summary
The agencies established a joint team to address concern and confusion in the lab community about the intersection between the Quality System Regulation and CMS’s CLIA oversight process.